These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 4949222)

  • 1. [Antiviral properties of pseudomonas].
    Bobir AD; Diachok VV
    Mikrobiol Zh; 1971; 33(5):562-8. PubMed ID: 4949222
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of polysaccharide-containing fractions from Gram negative bacteria on adenovirus type 3 and tobacco mosaic virus].
    Mil'chenko KP; Kahanskaia MB
    Mikrobiol Zh; 1970; 32(3):366-9. PubMed ID: 4931218
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemical nature and properties of an inhibitor of tobacco mosaic virus isolated from Pseudomonas longa (Zimm.) Migula].
    Iazykova TF; Mozhaeva KA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1973; 115(7):100-2. PubMed ID: 4770222
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiviral properties of the pigments from bacteria of the genus Pseudomonas].
    Mil'chenko KP; Kiprianova EA; Boĭko OI
    Mikrobiol Zh; 1976; 38(1):24-8. PubMed ID: 823395
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the effect of constant magnetic field on tobacco mosaic virus synthesis in tobacco leaves.
    Maj Z; Dutczak K
    Acta Microbiol Pol A; 1970; 2(3):143-8. PubMed ID: 5486456
    [No Abstract]   [Full Text] [Related]  

  • 6. Discovery of bitriazolyl compounds as novel antiviral candidates for combating the tobacco mosaic virus.
    Xia Y; Fan Z; Yao J; Liao Q; Li W; Qu F; Peng L
    Bioorg Med Chem Lett; 2006 May; 16(10):2693-8. PubMed ID: 16504509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of the products of the vital activity of yeasts on the tobacco mosaic virus].
    Bobyr' AD; Glushak LE
    Mikrobiol Zh; 1965; 27(2):73-8. PubMed ID: 5869334
    [No Abstract]   [Full Text] [Related]  

  • 8. Purification and some properties of an extracellular ribonuclease with antiviral activity against tobacco mosaic virus from Bacillus cereus.
    Zhou WW; Niu TG
    Biotechnol Lett; 2009 Jan; 31(1):101-5. PubMed ID: 18777010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco mosaic virus-like particles in mammalian cells inoculated with TMV ribonucleic acid.
    Chýle M; Chýle P; Korb J; Patocka F
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(1):122-3. PubMed ID: 5062513
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antiviral action of some soil mycobacteria on the tobacco mosaic virus].
    Mil'chenko KP; Orishchuk LF
    Mikrobiol Zh; 1972; 33(2):265-7. PubMed ID: 4663650
    [No Abstract]   [Full Text] [Related]  

  • 11. Tobacco mosaic virus-induced resistance to Pseudomonas tabaci in tobacco.
    Lovrekovich L; Lovrekovich H; Stahmann MA
    Phytopathology; 1968 Jul; 58(7):1034-5. PubMed ID: 5729091
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiviral properties of a yeast extract].
    Kovalenko AG
    Mikrobiol Zh; 1970; 32(3):398-400. PubMed ID: 5517390
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of the action of Candida tropicalis K-41 polysaccharides on the infectivity of the tobacco mosaic virus and its RNA].
    Kovalenko AG; Barkalova AA; Mikheeva II
    Mikrobiol Zh (1978); 1981; 43(5):633-9. PubMed ID: 7311898
    [No Abstract]   [Full Text] [Related]  

  • 14. [Isolation, purification and some properties of antiviral substances from the yeast].
    Kovalenko AG
    Mikrobiol Zh; 1971; 33(1):75-82. PubMed ID: 5559346
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of tobacco mosaic virus by a bacterial extract.
    Mann EW
    Phytopathology; 1969 May; 59(5):658-62. PubMed ID: 5786563
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and antiviral activity against tobacco mosaic virus and 3D-QSAR of alpha-substituted-1,2,3-thiadiazoleacetamides.
    Zhao WG; Wang JG; Li ZM; Yang Z
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6107-11. PubMed ID: 17055269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of laurusin (formycin B) on tobacco mosaic virus multiplication and its symptom development.
    Huang KT; Katagiri M; Misato T
    J Antibiot (Tokyo); 1966 Mar; 19(2):75-7. PubMed ID: 5952895
    [No Abstract]   [Full Text] [Related]  

  • 18. Tunicamycin, a new antibiotic. II. Some biological properties of the antiviral activity of tunicamycin.
    Takatsuki A; Tamura G
    J Antibiot (Tokyo); 1971 Apr; 24(4):224-31. PubMed ID: 5103138
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bacuchiol activity against the tobacco mosaic virus].
    Prikhod'ko VA; Zhmurko LI; Bobyr' AD; Meshcheriakov AA
    Mikrobiol Zh (1978); 1982; 44(3):73-4. PubMed ID: 7121325
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tobacco mosaic virus inhibitors of actinomycetales living in soil].
    Schimanski HH; Klinkowski M; Einleitung A
    Zentralbl Bakteriol Parasitenkd Infektionskr Hyg; 1969; 123(5):473-500. PubMed ID: 5395913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.